Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Use for 2 or more years of proton pump inhibitors and histamine 2 receptor antagonists (two types of acid-inhibiting medications) was associated with a subsequent new diagnosis of vitamin B 12 deficiency, according to a study appearing in the December 11 issue of JAMA.
"Vitamin B 12 deficiency is relatively common, especially among older adults; it has potentially serious medical complications if undiagnosed. Left untreated, vitamin B 12 deficiency can lead to dementia, neurologic damage, anemia, and other complications, which may be irreversible," according to background information in the article. Proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H 2 RAs) suppress the production of gastric acid, which may lead to malabsorption of vitamin B 12 , and they are among the most commonly used pharmaceuticals in the United States. However, few data exist about any association between long-term exposure to these medications and vitamin B 12 deficiency in large population-based studies.
Jameson R. Lam, M.P.H., of Kaiser Permanente, Oakland, Calif., and colleagues evaluated the relationship between the use of acid-suppressing prescription medications and vitamin B 12 deficiency within the Kaiser Permanente Northern California population. The researchers identified 25,956 patients having new diagnoses of vitamin B 12 deficiency between January 1997 and June 2011 and 184,199 patients without B 12 deficiency, and compared their exposure to acid inhibitors as observed via electronic pharmacy, laboratory, and diagnostic databases.
Among patients with a new diagnosis of vitamin B 12 deficiency, 3,120 (12.0 percent) were dispensed a 2 or more years' supply of PPIs, 1,087 (4.2 percent) were dispensed a 2 or more years' supply of H 2 RAs (without any PPI use), and 21,749 (83.8 percent) had not received prescriptions for either PPIs or H 2 RAs. Among control patients, 13,210 (7.2 percent) were dispensed a 2 or more years' supply of PPIs, 5,897 (3.2 percent) were dispensed a 2 or more years' supply of H 2 RAs (without any PPI use), and 165,092 (89.6 percent) had not received prescriptions for either PPIs or H 2 RAs.
Receiving 2 or more years' supply of PPIs and H 2 RAs was associated with increased risk for vitamin B 12 deficiency. Doses more than 1.5 PPI pills/day were more strongly associated with vitamin B 12 deficiency than were doses less than 0.75 pills/day.
The researchers found that the magnitude of the association was stronger in women and younger age groups with more potent acid suppression (PPIs vs. H 2 RAs), and that the association decreased after discontinuation of use. There was no significant trend with increasing duration of use.
"We cannot completely exclude residual confounding [factors besides the drugs] as an explanation for these findings, but, at minimum, the use of these medications identifies a population at higher risk of B 12 deficiency, independent of additional risk factors. These findings do not recommend against acid suppression for persons with clear indications for treatment, but clinicians should exercise appropriate vigilance when prescribing these medications and use the lowest possible effective dose. These findings should inform discussions contrasting the known benefits with the possible risks of using these medications," the authors conclude.
This project was supported by a Kaiser Permanente Community Benefit grant. All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr. Corley reported receiving a grant or grant pending from Wyeth/Pfizer. No other authors reported disclosures.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our GastroIntestinal / Gastroenterology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
JAMA. "Acid-suppressing medications associated with vitamin B12 deficiency." Medical News Today. MediLexicon, Intl., 10 Dec. 2013. Web.
7 Mar. 2014. <http://www.medicalnewstoday.com/releases/269846>
JAMA. (2013, December 10). "Acid-suppressing medications associated with vitamin B12 deficiency." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/269846.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.